Literature DB >> 26077756

Host immune response is severely compromised during lethal Plasmodium vinckei infection.

Jyoti Bhardwaj1, Arif Jamal Siddiqui, Manish Goyal, Kirtika Prakash, Awakash Soni, Sunil K Puri, Mrigank Srivastava.   

Abstract

Cytokines and immune effector cells play an important role in determining the outcome of infection with various intracellular pathogens, including protozoan parasites. However, their role during lethal and nonlethal malaria needs further validation. In the present study, we examined the role of cytokines and various immune effector cells during lethal and nonlethal malaria caused by Plasmodium vinckei in AKR mice. We show that lethal P. vinckei infection (PvAS) in AKR mice is characterized by increased parasite growth, decreased production of pro-inflammatory cytokines, and attenuated cell proliferation and nitric oxide (NO) synthesis resulting in increased parasitemia which ultimately leads to death of all animals by day 5 post infection. In contrast, AKR mice infected with lethal parasite (PvAR) showed elevated levels of pro-inflammatory cytokines, heightened cell proliferation, and NO synthesis leading to complete parasite clearance by day 22 post infection. Flow cytometric analysis performed on splenocytes from PvAS- and PvAR-infected mice shows that host immunity is severely compromised in PvAS-infected mice as was evident by decreased percentages of CD4(+) and CD8(+) T cells, B cells, plasma cells, dendritic cells (DCs), and macrophages (MΦs) which was in complete contrast to PvAR-infected animals which exhibited elevated numbers of all the cell types analyzed. Taken together, findings of the present study show that coordinated actions of pro-inflammatory cytokines and other immune effector cells are essential to control lethal malarial infection and their attenuation leads to increased parasite growth and, ultimately, death of animals.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077756     DOI: 10.1007/s00436-015-4570-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  49 in total

Review 1.  Malaria and the immune system in humans.

Authors:  Peter Perlmann; Marita Troye-Blomberg
Journal:  Chem Immunol       Date:  2002

2.  Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii.

Authors:  Anmol Chandele; Paushali Mukerjee; Gobardhan Das; Rafi Ahmed; Virander S Chauhan
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

3.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 4.  Plasmodium falciparum malaria vaccines: current status, pitfalls and future directions.

Authors:  Aiala Salvador; Rosa M Hernández; José Luis Pedraz; Manoli Igartua
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217

5.  Anemia in experimental malaria. (Plasmodium berghei, P. vinckei).

Authors:  W Kretschmar
Journal:  Ann Soc Belges Med Trop Parasitol Mycol       Date:  1969

Review 6.  Immunological processes in malaria pathogenesis.

Authors:  Louis Schofield; Georges E Grau
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

7.  Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS.

Authors:  H Helmby; G Jönsson; M Troye-Blomberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

9.  Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites.

Authors:  Lilian Lacerda Bueno; Cristiane Guimarães Morais; Fernanda Fortes Araújo; Juliana Assis Silva Gomes; Rodrigo Corrêa-Oliveira; Irene Silva Soares; Marcus Vinícius Lacerda; Ricardo Toshio Fujiwara; Erika Martins Braga
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.

Authors:  J M Vinetz; S Kumar; M F Good; B J Fowlkes; J A Berzofsky; L H Miller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

View more
  4 in total

1.  Impact of chemoprophylaxis immunisation under halofantrine (CPS-HF) drug cover in Plasmodium yoelii Swiss mice malaria model.

Authors:  Arif Jamal Siddiqui; Jyoti Bhardwaj; Walid Sabri Hamadou; Manish Goyal; Sadaf Jahan; Syed Amir Ashraf; Arshad Jamal; Pankaj Sharma; Manojkumar Sachidanandan; Riadh Badraoui; Mejdi Snoussi; Mohd Adnan
Journal:  Folia Parasitol (Praha)       Date:  2022-02-03       Impact factor: 2.122

Review 2.  Fish-based Bioactives as Potent Nutraceuticals: Exploring the Therapeutic Perspective of Sustainable Food from the Sea.

Authors:  Syed Amir Ashraf; Mohd Adnan; Mitesh Patel; Arif Jamal Siddiqui; Manojkumar Sachidanandan; Mejdi Snoussi; Sibte Hadi
Journal:  Mar Drugs       Date:  2020-05-18       Impact factor: 5.118

Review 3.  Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic Cordyceps Medicinal Fungus and Its Nutraceutical and Therapeutic Potential.

Authors:  Syed Amir Ashraf; Abd Elmoneim O Elkhalifa; Arif Jamal Siddiqui; Mitesh Patel; Amir Mahgoub Awadelkareem; Mejdi Snoussi; Mohammad Saquib Ashraf; Mohd Adnan; Sibte Hadi
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

4.  Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.

Authors:  Arif Jamal Siddiqui; Sadaf Jahan; Syed Amir Ashraf; Mousa Alreshidi; Mohammad Saquib Ashraf; Mitesh Patel; Mejdi Snoussi; Ritu Singh; Mohd Adnan
Journal:  J Biomol Struct Dyn       Date:  2020-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.